PTPN6 and neoplasm: We administered tamoxifen according to the regimen outlined in Figure 2A and implanted syngeneic mouse tumor cells 3 days after the final tamoxifen dose, a time selected to coincide with initial Shp1 protein loss in mouse peripheral blood cells.